These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31062443)

  • 1. Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix) during the 2009 H1N1 influenza pandemic.
    Granath F; Gedeborg R; Smedje H; Feltelius N
    Pharmacoepidemiol Drug Saf; 2019 Aug; 28(8):1045-1053. PubMed ID: 31062443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.
    Dauvilliers Y; Arnulf I; Lecendreux M; Monaca Charley C; Franco P; Drouot X; d'Ortho MP; Launois S; Lignot S; Bourgin P; Nogues B; Rey M; Bayard S; Scholz S; Lavault S; Tubert-Bitter P; Saussier C; Pariente A;
    Brain; 2013 Aug; 136(Pt 8):2486-96. PubMed ID: 23884811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England.
    Stowe J; Andrews N; Kosky C; Dennis G; Eriksson S; Hall A; Leschziner G; Reading P; Shneerson JM; Donegan K; Miller E
    Sleep; 2016 May; 39(5):1051-7. PubMed ID: 26856903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants.
    Ahmed SS; Schur PH; MacDonald NE; Steinman L
    J Autoimmun; 2014 May; 50():1-11. PubMed ID: 24559657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010.
    O'Flanagan D; Barret AS; Foley M; Cotter S; Bonner C; Crowe C; Lynch B; Sweeney B; Johnson H; McCoy B; Purcell E
    Euro Surveill; 2014 May; 19(17):15-25. PubMed ID: 24821121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study.
    Dodd CN; de Ridder M; Huang WT; Weibel D; Giner-Soriano M; Perez-Vilar S; Diez-Domingo J; Svenson LW; Mahmud SM; Carleton B; Naus M; Kwong JC; Murray BJ; Arnheim-Dahlstrom L; Pedersen L; Morros R; Puertas FJ; Black S; Sturkenboom M
    PLoS One; 2018; 13(10):e0204799. PubMed ID: 30332477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis.
    Miller E; Andrews N; Stellitano L; Stowe J; Winstone AM; Shneerson J; Verity C
    BMJ; 2013 Feb; 346():f794. PubMed ID: 23444425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study.
    Stowe J; Andrews N; Gringras P; Quinnell T; Zaiwalla Z; Shneerson J; Miller E
    PLoS Med; 2020 Sep; 17(9):e1003225. PubMed ID: 32926731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narcolepsy and Pandemic Influenza Vaccination: What We Need to Know to be Ready for the Next Pandemic.
    Edwards K; Lambert PH; Black S
    Pediatr Infect Dis J; 2019 Aug; 38(8):873-876. PubMed ID: 31306400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of narcolepsy before and after MF59-adjuvanted influenza A(H1N1)pdm09 vaccination in South Korean soldiers.
    Kim WJ; Lee SD; Lee E; Namkoong K; Choe KW; Song JY; Cheong HJ; Jeong HW; Heo JY
    Vaccine; 2015 Sep; 33(38):4868-72. PubMed ID: 26238720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns.
    Wijnans L; Lecomte C; de Vries C; Weibel D; Sammon C; Hviid A; Svanström H; Mølgaard-Nielsen D; Heijbel H; Dahlström LA; Hallgren J; Sparen P; Jennum P; Mosseveld M; Schuemie M; van der Maas N; Partinen M; Romio S; Trotta F; Santuccio C; Menna A; Plazzi G; Moghadam KK; Ferro S; Lammers GJ; Overeem S; Johansen K; Kramarz P; Bonhoeffer J; Sturkenboom MC
    Vaccine; 2013 Feb; 31(8):1246-54. PubMed ID: 23246544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Narcolepsy and 2009 H1N1 pandemic vaccination in Taiwan.
    Huang WT; Huang YS; Hsu CY; Chen HC; Lee HC; Lin HC; Hsieh CF; Wu MN; Yang CH
    Sleep Med; 2020 Feb; 66():276-281. PubMed ID: 30579702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden.
    Bardage C; Persson I; Ortqvist A; Bergman U; Ludvigsson JF; Granath F
    BMJ; 2011 Oct; 343():d5956. PubMed ID: 21994316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting.
    Edwards K; Hanquet G; Black S; Mignot E; Jankosky C; Shimabukuro T; Miller E; Nohynek H; Neels P
    Biologicals; 2019 Jul; 60():1-7. PubMed ID: 31130313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland.
    Nohynek H; Jokinen J; Partinen M; Vaarala O; Kirjavainen T; Sundman J; Himanen SL; Hublin C; Julkunen I; Olsén P; Saarenpää-Heikkilä O; Kilpi T
    PLoS One; 2012; 7(3):e33536. PubMed ID: 22470453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.
    Lind A; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Nilsson AL; Bomfim IL; Fink K; Lernmark Å
    J Autoimmun; 2014 May; 50():99-106. PubMed ID: 24485154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Did narcolepsy occur following administration of AS03-adjuvanted A(H1N1) pandemic vaccine in Ontario, Canada? A review of post-marketing safety surveillance data.
    Harris T; Wong K; Stanford L; Fediurek J; Crowcroft N; Deeks S
    Euro Surveill; 2014 Sep; 19(36):. PubMed ID: 25232921
    [No Abstract]   [Full Text] [Related]  

  • 19. A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden.
    Feltelius N; Persson I; Ahlqvist-Rastad J; Andersson M; Arnheim-Dahlström L; Bergman P; Granath F; Adori C; Hökfelt T; Kühlmann-Berenzon S; Liljeström P; Maeurer M; Olsson T; Örtqvist Å; Partinen M; Salmonson T; Zethelius B
    J Intern Med; 2015 Oct; 278(4):335-53. PubMed ID: 26123389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.
    Saariaho AH; Vuorela A; Freitag TL; Pizza F; Plazzi G; Partinen M; Vaarala O; Meri S
    J Autoimmun; 2015 Sep; 63():68-75. PubMed ID: 26227560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.